产品详情
靶点信息
In vitro | DMSO | 56 mg/mL (184.05 mM) | |
Water | Insoluble | ||
Ethanol | 56 mg/mL (184.05 mM) | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 32.86 mL | 164.31 mL | 328.62 mL |
0.5 mM | 6.57 mL | 32.86 mL | 65.72 mL |
1 mM | 3.29 mL | 16.43 mL | 32.86 mL |
5 mM | 0.66 mL | 3.29 mL | 6.57 mL |
*The above data is based on the productmolecular weight 304.3 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
目录号 | A10893 |
---|---|
作用机制 | Inhibitor (抑制剂) |
M. Wt | 304.3 |
Formula | C15H12O7 |
Purity | >99% |
Storage | Store lyophilized at -20ºC, keep desiccated. |
CAS No. | 480-18-2 |
Synonyms | Dihydroquercetin, Taxifoliol, Distylin, Catechin hydrate, (+)-Taxifolin, trans-Dihydroquercetin, (+)-Dihydroquercetin |
SMILES | C1=CC(=C(C=C1[C@@H]2[C@H](C(=O)C3=C(C=C(C=C3O2)O)O)O)O)O |
产品标签
Product Questions
Product Questions
Vandetanib (ZD6474)
Vandetanib (ZD6474)是一种VEGFR和EGFR拮抗剂,是一种酪氨酸激酶抑制剂,对于HUVEC增殖,PC-9细胞和酪氨酸激酶活…
Apatinib (YN968D1)
Apatinib (YN968D1)是一种酪氨酸激酶抑制剂,可选择性抑制血管内皮生长因子受体2(VEGFR2,也称为KDR),后者…
Motesanib (AMG706)
Motesanib(AMG706)是一种多激酶抑制剂,可选择性靶向VEGF受体,血小板衍生的生长因子受体(PDGFRs)和Kit受体…
TSU-68 (Orantinib, SU6668)
TSU-68 (Orantinib,SU6668)在无细胞试验中具有8 nM的Ki对PDGFR自磷酸化的最大效力,但也强烈抑制Flk-1和FGFR1反磷酸…
BMS-690514
BMS-690514是一种有效的选择性表皮生长因子受体(EGFR),HER2和HER4抑制剂,以及VEGF受体激酶。
Raf265 derivative
Raf265 derivative是Raf265的衍生物,Raf265是一种口服,高度选择性的RAF和VEGFR激酶抑制剂,IC50为5至10μM。
SU 5416 (Semaxinib)
SU 5416 (Semaxinib)是血管内皮生长因子受体(VEGFR)的抑制剂,它还抑制其他酪氨酸激酶KIT,MET,FLT3和RET。